The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Thanks very much
Thanks
Will the Gates foundation be using this test in the low income countries still?
I have been trying to read through the RNS’s and I thought I read before that they have the exclusive rights to the Mologic test but I have not been able to find that info yet. Does anyone know?
Thanks
The ABDX RNS is not really news we all knew that was happening and should have happened by now. When I say don’t get spiked I mean don’t think this the the only chance to get in based on nothing really.
I agree if you are trying to trade then you certainly would not want to listen to what’s going on here. Probably best to do the opposite of sentiment.
I see there is a lot of ramping without news today. Don’t forget the price was a buy for traders a couple of days ago so they will be now trying to push sentiment up to get the price to their exit point.
Don’t get excited by the ramping as you will get spiked, unless news comes this will go down again. It has done it lots of times before.
Regardless of who it is Avacta have submitted their test for HUA as have ODX so I wonder why Bell says we have one nearly ready when clearly we have two? Unless they are sticking to N protein for the U.K. and as ours is S they are ruling it out?
What I’m getting from this is Medusa want to sell tests and as they can not sell Avacta yet they are going to sell other tests. I’m sure they will sell our test well once they are able to but they are not going to just sit around if there are other tests they can sell too.
I cannot understand how Avacta can be so undervalued compared to other companies I keep an eye on such as Sareum 230 mil market cap and Angle 280 million market cap. And those companies have got nothing currently compared to Avacta which has proven tech and many different avenues income generation ongoing. It will be interesting to see how long the price will be kept down, It almost seems that the Lft Is currently working against the share price as most investors don’t seem to value any other part of the company and just want to hear about lft sales as though the rest of the company does not exist. Surely the correct value of Avacta must be at least the 280 high it reached just with what we already have.
I find this board a much more pleasant read after filtering everyone I consider suspicious. That does not mean everyone who may occasionally post a negative remark or some genuine bad news, but rather those who are always negative and those who change sides erratically. I do not feel those characters have anything useful to say and it’s a good feeling to know their rantings are not achieving their objective with me because I have no idea what they are saying. Also if they pop up again under a new name you can spot it right away and they go right in the bin.